Founder and Chief Scientific Director
Sherry Bradford completed her PhD at the New York State University at Buffalo Medical School/Roswell Park Cancer Institute Division. She is the founder and Chief Scientific Director of AccuTheranostics, a premier biotechnology research and clinical laboratory services, located in the heart of Buffalo’s Medical Corridor. She has published many papers/book chapters, been an invited speaker at many national/international meetings and is currently serving as an editorial board member of peer-reviewed journals. She holds 2 patents and 3 pending.
“Breast Cancer and Personalized Medicine: A Perspective on How to Improve Prudence and Pioneer Cancer Treatment Reforms.”